The effects of suvorexant on sleep disorder and clinical findings of hemodialysis patients
Not Applicable
Recruiting
- Conditions
- Insomnia, maintenance hemodialysis patient
- Registration Number
- JPRN-UMIN000023199
- Lead Sponsor
- Toda Central General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe liver dysfunction 2. Severe respiratory dysfunction 3. Severe brain disorder 4. Patients having agents inhibiting CYP3A 5. Patients with severe dementia 6. Patients with no sleep wake rhythm due to bedridden state
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Athens insomnia scale
- Secondary Outcome Measures
Name Time Method 1. Adverse effects 2. Self administered questionnaire about insomnia 3. Clinical findings (BMI, pre dialysis blood pressure, interdialytic weight gain, change of blood pressure during dialysis) and blood examinations